CJC-1295 + Ipamorelin Blend
Lyophilised powder — vial
CJC-1295 + Ipamorelin, 99% purity, for laboratory research use. A research blend of a GHRH-analogue peptide and a selective ghrelin-receptor agonist, studied in vitro for growth-hormone secretagogue activity.
- Peptide research blend (GHRH analogue + ghrelin-receptor agonist)
- ≥ 99%+ purity (HPLC)
- Store lyophilised at −20 °C, protect from light
- Lyophilised powder, single sealed vial
For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.
Certificate of Analysis (COA)20 mg
99%+
650 AED
| CAS | 863288-34-0 / 170851-70-4 |
| Molecular mass | — |
| Molecular formula | — |
| Sequence | — |
| Form | Lyophilised powder, single sealed vial |
| Purity | ≥ 99%+ |
| Storage | −20 °C, protect from light |
| COA | Available on request |
Independently third-party tested · COA available on request.
Research Use Only
This product is intended for laboratory research use only. It is not a drug, food, or cosmetic, and is not intended for human or animal use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes.
Related Compounds
CJC-1295 No DAC + Ipamorelin
GHRH analogue + GH secretagogue blend
Peptide research blend (GHRH analogue + ghrelin-receptor agonist)
750 AED
CJC-1295 No DAC
Modified GRF (1-29)
Synthetic GHRH-analogue peptide (Modified GRF 1-29)
650 AED
Ipamorelin
Synthetic pentapeptide (ghrelin-receptor agonist)
700 AED
Tesamorelin
Synthetic GHRH-analogue peptide
900 AED